FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 305:63-67 July 9, 1981 Number 2 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

We conducted a double-blind, placebo-controlled study of acyclovir prophylaxis against infection with herpes simplex virus (HSV) in 20 seropositive recipients of bone-marrow transplants. Acyclovir or placebo was administered for 18 days, starting three days before transplantation. Culture-positive HSV lesions developed during the study in seven of the 10 patients who received placebo. In contrast, no such lesions appeared in the 10 patients who received acyclovir (P congruent to 0.003). None of the patients had evidence of drug toxicity. Five of the patients treated with acyclovir had mild culture-positive HSV infections after cessation of the drug, and two additional patients shed virus without having lesions. Acyclovir appears to be a potent inhibitor of HSV replication. Although acyclovir does no appear to eradicate latent infection, it can provide effective prophylaxis against reactivated infections.

This article has been cited by other articles:

• Sandherr, M., Einsele, H., Hebart, H., Kahl, C., Kern, W., Kiehl, M., Massenkeil, G., Penack, O., Schiel, X., Schuettrumpf, S., Ullmann, A. J., Cornely, O. A. (2006). Antiviral prophylaxis in patients with haematological malignancies and solid tumours: Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Oncology (DGHO). Ann Oncol 17: 1051-1059 [Abstract] [Full Text]  
• Kruger, W. H., Bohlius, J., Cornely, O. A., Einsele, H., Hebart, H., Massenkeil, G., Schuttrumpf, S., Silling, G., Ullmann, A. J., Waldschmidt, D. T., Wolf, H.-H. (2005). Antimicrobial prophylaxis in allogeneic bone marrow transplantation. Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Haematology and Oncology. Ann Oncol 16: 1381-1390 [Abstract] [Full Text]  
• Hellden, A., Odar-Cederlof, I., Diener, P., Barkholt, L., Medin, C., Svensson, J.-O., Sawe, J., Stahle, L. (2003). High serum concentrations of the acyclovir main metabolite 9-carboxymethoxymethylguanine in renal failure patients with acyclovir-related neuropsychiatric side effects: an observational study. Nephrol Dial Transplant 18: 1135-1141 [Abstract] [Full Text]  
• Jenkins, F. J., Rowe, D. T., Rinaldo, C. R. Jr. (2003). Herpesvirus Infections in Organ Transplant Recipients. CVI 10: 1-7 [Full Text]  
• Bacon, T. H., Levin, M. J., Leary, J. J., Sarisky, R. T., Sutton, D. (2003). Herpes Simplex Virus Resistance to Acyclovir and Penciclovir after Two Decades of Antiviral Therapy. Clin. Microbiol. Rev. 16: 114-128 [Abstract] [Full Text]  
• Tabbara, I. A., Zimmerman, K., Morgan, C., Nahleh, Z. (2002). Allogeneic Hematopoietic Stem Cell Transplantation: Complications and Results. Arch Intern Med 162: 1558-1566 [Abstract] [Full Text]  
• Langston, A. A., Redei, I., Caliendo, A. M., Somani, J., Hutcherson, D., Lonial, S., Bucur, S., Cherry, J., Allen, A., Waller, E. K. (2002). Development of drug-resistant herpes simplex virus infection after haploidentical hematopoietic progenitor cell transplantation. Blood 99: 1085-1088 [Abstract] [Full Text]  
• Khan, S. A., Wingard, J. R. (2001). Infection and Mucosal Injury in Cancer Treatment. J Natl Cancer Inst Monogr 2001: 31-36 [Abstract] [Full Text]  
• (2000). Management of herpes virus infections following transplantation. J Antimicrob Chemother 45: 729-748 [Full Text]  
• Mackall, C. L. (2000). T-Cell Immunodeficiency Following Cytotoxic Antineoplastic Therapy: A Review. Stem Cells 18: 10-18 [Abstract] [Full Text]  
• Mackall, C. L. (1999). T-Cell Immunodeficiency Following Cytotoxic Antineoplastic Therapy: A Review. The Oncologist 4: 370-378 [Abstract] [Full Text]  
• Balfour, H. H. (1999). Antiviral Drugs. NEJM 340: 1255-1268 [Full Text]  
• Woo, S.-B., Lee, S. J., Schubert, M. M. (1997). Graft-vs.-Host Disease. CROBM 8: 201-216 [Abstract] [Full Text]  
• Bergmann, O. J, Ellermann-Eriksen, S., Mogensen, S. C, Ellegaard, J. (1995). Acyclovir given as prophylaxis against oral ulcers in acute myeloid leukaemia: randomised, double blind, placebo controlled trial. BMJ 310: 1169-1172 [Abstract] [Full Text]  
• Pizzo, P. A. (1993). Management of Fever in Patients with Cancer and Treatment-Induced Neutropenia. NEJM 328: 1323-1332 [Full Text]  
• Elion, G. (1989). The purine path to chemotherapy. Science 244: 41-47 [Abstract]  
• Shannon, K. M., Cowan, M. J., Matthay, K. K. (1987). Pediatric Bone Marrow Transplantation: Intensive Care Management. J Intensive Care Med 2: 328-344 [Abstract]  
• Saito, Y, Price, R., Rottenberg, D., Fox, J., Su, T., Watanabe, K., Philips, F. (1982). Quantitative autoradiographic mapping of herpes simplex virus encephalitis with a radiolabeled antiviral drug. Science 217: 1151-1153 [Abstract]